吸入麻酔薬市場：タイプ、作用時間、用途、最終用途別-2025-2030年の世界予測

吸入麻酔薬市場は、2023年に17億米ドルと評価され、2024年には18億8,000万米ドルに達すると予測され、CAGR 11.01%で成長し、2030年には35億4,000万米ドルに達すると予測されています。

吸入麻酔薬市場には、主に外科手術中の全身麻酔の導入と維持に使用されるさまざまなガス状薬剤が含まれます。これらの薬剤には、セボフルラン、デスフルラン、イソフルランなどが含まれ、患者の固定、健忘、鎮痛を確保するために不可欠です。吸入麻酔薬の必要性は、高齢化社会と心血管疾患やがんなどの慢性疾患の有病率の増加により、世界的に外科手術の件数が増加していることからも明らかです。これらの麻酔薬は、病院や外来手術センターだけでなく、歯科手術、獣医手術、外来患者での使用も増えており、最終用途の範囲が拡大しています。

市場成長は、ヘルスケアインフラの進歩、外科手術の増加、麻酔デリバリーシステムの開発などの技術革新に大きく影響されます。さらに、低侵襲手術に対する需要の高まりや、静脈注射に代わる選択肢と比べた吸入麻酔薬の費用対効果も、大きな成長機会をもたらしています。しかし、厳しい規制当局の承認、潜在的な副作用、温室効果ガス排出に関する環境問題などの課題が市場拡大の妨げとなっています。また、開発途上地域では価格に敏感であることも、制約に拍車をかけています。

市場機会を生かすため、企業は副作用が少なく環境への影響が少ない、より新しい麻酔薬の研究開発に注力することが推奨されます。これらの薬剤の安全な使用と取り扱いに関するヘルスケアプロバイダーへの教育を重視することで、市場への浸透を高めることができます。さらに、医療団体との提携や、外科手術の需要が高い地域市場への参入は、有利な成長の道を提供することができます。革新的な技術としては、投与効率と環境フットプリントを最適化するドラッグデリバリーシステムが挙げられます。全体として、市場は競合が激しいが、規制や環境面での課題はあるもの、医療行為や技術の進化が市場の成長を後押ししています。

市場力学：急速に進化する吸入麻酔薬市場の主要市場インサイトを公開

吸入麻酔薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の手術件数と慢性疾患の増加、および低侵襲治療の必要性
  • 外科手術に対する政府の承認と償還政策が良好であること
• 市場抑制要因
  • 吸入麻酔薬の製品回収に伴う潜在的リスク
• 市場機会
  • 効果的なナノベースのドラッグデリバリーシステムの統合吸入麻酔薬
  • 合成麻酔薬および非オピオイド麻酔薬の研究開発への投資
• 市場の課題
  • 吸入麻酔薬に伴う副作用

ポーターのファイブフォース：吸入麻酔薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：吸入麻酔薬市場における外部からの影響の把握

外部マクロ環境要因は、吸入麻酔薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析吸入麻酔薬市場における競合情勢の把握

吸入麻酔薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス吸入麻酔薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、吸入麻酔薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨吸入麻酔薬市場における成功への道筋を描く

吸入麻酔薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で手術や慢性疾患が増加し、低侵襲治療の選択肢の必要性が高まっている
    • 外科手術に対する政府の有利な承認と償還政策
  • 抑制要因
    • 吸入麻酔薬の製品回収に伴う潜在的なリスク
  • 機会
    • 効果的なナノベースのドラッグデリバリーシステムの統合吸入麻酔薬
    • 合成および非オピオイド麻酔薬の研究開発への投資
  • 課題
    • 吸入麻酔薬に伴う副作用
• 市場セグメンテーション分析
  • タイプ：デスフルランは、回復が早く、予測可能で、頭がはっきりしているという利点があるため、麻酔薬として利用されています。
  • 応用：複雑な手術プロセスにおける疼痛管理のための吸入麻酔薬の使用の増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 吸入麻酔薬市場：タイプ別

• デスフルラン
• ハロタン
• イソフルラン
• 亜酸化窒素
• セボフルラン

第7章 吸入麻酔薬市場作用持続時間別

• 長時間作用型
• 短時間作用型

第8章 吸入麻酔薬市場：用途別

• 診断手順
• 緊急ケア
• 外科手術
  • 心臓血管外科
  • 一般外科
  • 婦人科手術
  • 脳神経外科
  • 整形外科

第9章 吸入麻酔薬市場：最終用途別

• 外来手術センター
• 病院

第10章 南北アメリカの吸入麻酔薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の吸入麻酔薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの吸入麻酔薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • AANA、麻酔ガス廃棄の安全処分に関する新ガイドラインを発表
  • ベネンデン病院がセージテックメディカルの環境に優しい麻酔ガスリサイクル技術を採用
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Aesica Queenborough Limited
• Akorn, Inc.
• Aspen Pharmacare Holdings Limited
• Baxter International Inc.
• BOC Healthcare
• Draegerwerk AG & Co. KGaA
• Eagle Pharmaceuticals
• Fresenius Kabi AG
• GE HealthCare Technologies, Inc.
• Halocarbon Life Sciences
• Hikma Pharmaceuticals PLC
• Intersurgical Ltd
• Jiangsu Hengrui Medicine Co., Ltd.
• Linde PLC
• Lunan Pharmaceutical Group Co. Ltd.
• Maruishi Pharmaceutical Co., Ltd.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Piramal Enterprises Limited
• Teligent, Inc.
• Troikaa Pharmaceuticals Ltd.
• Vigon International Inc.
• Yichang Humanwell Pharmaceutical Co., Ltd.
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. INHALATION ANESTHETICS MARKET RESEARCH PROCESS
• FIGURE 2. INHALATION ANESTHETICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INHALATION ANESTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. INHALATION ANESTHETICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. INHALATION ANESTHETICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INHALATION ANESTHETICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INHALATION ANESTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INHALATION ANESTHETICS MARKET DYNAMICS
• TABLE 7. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DESFLURANE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HALOTHANE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ISOFLURANE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY NITROUS OXIDE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SEVOFLURANE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY LONG-ACTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SHORT-ACTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY EMERGENCY CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 47. CANADA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CANADA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 49. CANADA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 74. CHINA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. CHINA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 76. CHINA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 79. INDIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. INDIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 81. INDIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. ITALY INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 165. ITALY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. ITALY INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 167. ITALY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. POLAND INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 185. POLAND INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. POLAND INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 187. POLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. QATAR INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 190. QATAR INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. QATAR INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 192. QATAR INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 238. INHALATION ANESTHETICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 239. INHALATION ANESTHETICS MARKET, FPNV POSITIONING MATRIX, 2023

The Inhalation Anesthetics Market was valued at USD 1.70 billion in 2023, expected to reach USD 1.88 billion in 2024, and is projected to grow at a CAGR of 11.01%, to USD 3.54 billion by 2030.

The inhalation anesthetics market encompasses a range of gaseous agents used primarily for the induction and maintenance of general anesthesia during surgical procedures. These agents include sevoflurane, desflurane, and isoflurane, among others, and are integral in ensuring patient immobilization, amnesia, and analgesia. The necessity for inhalation anesthetics is underscored by the growing number of surgical procedures globally, driven by an aging population and the increasing prevalence of chronic diseases such as cardiovascular disorders and cancer. Beyond hospitals and ambulatory surgical centers, these anesthetics are increasingly being utilized in dental procedures, veterinary surgeries, and outpatient settings, thus expanding their end-use scope.

Market growth is significantly influenced by advancements in healthcare infrastructure, a rise in surgical procedures, and technological innovations like the development of anesthesia delivery systems. Additionally, the growing demand for minimally invasive surgeries and the cost-effectiveness of inhalation anesthetics compared to intravenous alternatives present substantial growth opportunities. However, challenges such as stringent regulatory approvals, potential side effects, and environmental concerns related to greenhouse gas emissions hinder market expansion. Price sensitivity in developing regions also adds to the limitations.

To capitalize on market opportunities, companies are advised to focus on research and development of newer anesthetic agents with reduced side effects and lower environmental impact. Emphasizing education for healthcare providers regarding the safe use and handling of these agents can enhance market penetration. Furthermore, partnerships with medical associations and participation in regional markets with high surgical demand can offer lucrative growth avenues. Innovations could target drug delivery systems that optimize dosing efficiency and environmental footprint. Overall, the market is competitive but poised for growth, driven by evolving medical practices and technology, despite underlying regulatory and environmental challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Inhalation Anesthetics Market

The Inhalation Anesthetics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in the number of surgeries and chronic diseases globally and the need for minimally invasive treatment options
  • Favorable government approvals and reimbursement policies for surgical procedures
• Market Restraints
  • Potential risk associated with the product recall of inhalation anesthetic drugs
• Market Opportunities
  • Integration of nano-based drug delivery systems for effective inhalation anesthetics
  • Investment in R&D for synthetic and non-opioid anesthetics
• Market Challenges
  • Side effects associated with inhalation anesthetic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Inhalation Anesthetics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Inhalation Anesthetics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Inhalation Anesthetics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Inhalation Anesthetics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Inhalation Anesthetics Market

A detailed market share analysis in the Inhalation Anesthetics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Inhalation Anesthetics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Inhalation Anesthetics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Inhalation Anesthetics Market

A strategic analysis of the Inhalation Anesthetics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Inhalation Anesthetics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aesica Queenborough Limited, Akorn, Inc., Aspen Pharmacare Holdings Limited, Baxter International Inc., BOC Healthcare, Draegerwerk AG & Co. KGaA, Eagle Pharmaceuticals, Fresenius Kabi AG, GE HealthCare Technologies, Inc., Halocarbon Life Sciences, Hikma Pharmaceuticals PLC, Intersurgical Ltd, Jiangsu Hengrui Medicine Co., Ltd., Linde PLC, Lunan Pharmaceutical Group Co. Ltd., Maruishi Pharmaceutical Co., Ltd., Merck & Co., Inc., Novartis AG, Pfizer Inc., Piramal Enterprises Limited, Teligent, Inc., Troikaa Pharmaceuticals Ltd., Vigon International Inc., Yichang Humanwell Pharmaceutical Co., Ltd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Inhalation Anesthetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Desflurane, Halothane, Isoflurane, Nitrous Oxide, and Sevoflurane.
• Based on Duration of Action, market is studied across Long-acting and Short-acting.
• Based on Application, market is studied across Diagnostic Procedures, Emergency Care, and Surgical Procedures. The Surgical Procedures is further studied across Cardiovascular Surgery, General Surgery, Gynecological Surgery, Neurosurgery, and Orthopedic Surgery.
• Based on End Use, market is studied across Ambulatory Surgical Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in the number of surgeries and chronic diseases globally and the need for minimally invasive treatment options
    • 5.1.1.2. Favorable government approvals and reimbursement policies for surgical procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Potential risk associated with the product recall of inhalation anesthetic drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of nano-based drug delivery systems for effective inhalation anesthetics
    • 5.1.3.2. Investment in R&D for synthetic and non-opioid anesthetics
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects associated with inhalation anesthetic drugs
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Utilization of Desflurane in anesthetics due to its advantage in rapid, predictable, and clear-headed recovery
  • 5.2.2. Application: Increasing usage of inhalation anesthetics for pain management in complex surgery process
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Inhalation Anesthetics Market, by Type

• 6.1. Introduction
• 6.2. Desflurane
• 6.3. Halothane
• 6.4. Isoflurane
• 6.5. Nitrous Oxide
• 6.6. Sevoflurane

7. Inhalation Anesthetics Market, by Duration of Action

• 7.1. Introduction
• 7.2. Long-acting
• 7.3. Short-acting

8. Inhalation Anesthetics Market, by Application

• 8.1. Introduction
• 8.2. Diagnostic Procedures
• 8.3. Emergency Care
• 8.4. Surgical Procedures
  • 8.4.1. Cardiovascular Surgery
  • 8.4.2. General Surgery
  • 8.4.3. Gynecological Surgery
  • 8.4.4. Neurosurgery
  • 8.4.5. Orthopedic Surgery

9. Inhalation Anesthetics Market, by End Use

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Hospitals

10. Americas Inhalation Anesthetics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Inhalation Anesthetics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Inhalation Anesthetics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. AANA issues new guidelines for safe disposal of waste anesthetic gases
  • 13.3.2. Benenden Hospital adopts SageTech Medical's eco-friendly anesthetic gas recycling technology
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Aesica Queenborough Limited
• 3. Akorn, Inc.
• 4. Aspen Pharmacare Holdings Limited
• 5. Baxter International Inc.
• 6. BOC Healthcare
• 7. Draegerwerk AG & Co. KGaA
• 8. Eagle Pharmaceuticals
• 9. Fresenius Kabi AG
• 10. GE HealthCare Technologies, Inc.
• 11. Halocarbon Life Sciences
• 12. Hikma Pharmaceuticals PLC
• 13. Intersurgical Ltd
• 14. Jiangsu Hengrui Medicine Co., Ltd.
• 15. Linde PLC
• 16. Lunan Pharmaceutical Group Co. Ltd.
• 17. Maruishi Pharmaceutical Co., Ltd.
• 18. Merck & Co., Inc.
• 19. Novartis AG
• 20. Pfizer Inc.
• 21. Piramal Enterprises Limited
• 22. Teligent, Inc.
• 23. Troikaa Pharmaceuticals Ltd.
• 24. Vigon International Inc.
• 25. Yichang Humanwell Pharmaceutical Co., Ltd.
• 26. Zoetis Inc.